140 related articles for article (PubMed ID: 35229064)
21. Hypoparathyroidism - management, information needs, and impact on daily living from the patients' perspective: results from a population-based survey.
Büttner M; Krogh D; Führer D; Fuß CT; Willenberg HS; Luster M; Singer S; Siggelkow H
Hormones (Athens); 2023 Sep; 22(3):467-476. PubMed ID: 37380916
[TBL] [Abstract][Full Text] [Related]
22. Trabecular bone score and bone mineral density in patients with postsurgical hypoparathyroidism after total thyroidectomy for differentiated thyroid carcinoma.
Iglesias SG; Dominguez MLM; Herrero EF; Martinez-Pueyo JI; Arroba CM; Diaz-Guerra GM; Hawkins Carranza F
Surgery; 2019 Apr; 165(4):814-819. PubMed ID: 30554726
[TBL] [Abstract][Full Text] [Related]
23. Assessment of quality of life in patients with permanent hypoparathyroidism receiving conventional treatment.
Cherchir F; Oueslati I; Yazidi M; Chaker F; Chihaoui M
J Diabetes Metab Disord; 2023 Dec; 22(2):1617-1623. PubMed ID: 37975128
[TBL] [Abstract][Full Text] [Related]
24. Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis.
Mortensen L; Hyldstrup L; Charles P
Eur J Endocrinol; 1997 Jan; 136(1):52-60. PubMed ID: 9037127
[TBL] [Abstract][Full Text] [Related]
25. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
[TBL] [Abstract][Full Text] [Related]
26. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series.
Bislev LS; Sikjaer T; Rejnmark L
Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672
[TBL] [Abstract][Full Text] [Related]
27. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism.
Underbjerg L; Sikjaer T; Rejnmark L
Clin Endocrinol (Oxf); 2018 Jun; 88(6):838-847. PubMed ID: 29520810
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism.
Meola A; Vignali E; Matrone A; Cetani F; Marcocci C
J Endocrinol Invest; 2018 Oct; 41(10):1221-1226. PubMed ID: 29516386
[TBL] [Abstract][Full Text] [Related]
30. [Hypoparathyroidism treated with recombinant human parathyroid hormone [rhPTH(1-84)]].
Ramacciotti CF; Pereyra MC; Cohen EN
Medicina (B Aires); 2020; 80(3):289-291. PubMed ID: 32442945
[TBL] [Abstract][Full Text] [Related]
31. Chronic hypoparathyroidism and treatment with teriparatide.
Marcucci G; Masi L; Cianferotti L; Giusti F; Fossi C; Parri S; Gronchi G; Brandi ML
Endocrine; 2021 Apr; 72(1):249-259. PubMed ID: 33538953
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
33. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
[TBL] [Abstract][Full Text] [Related]
36. Serum 1,25-Dihydroxyvitamin D as a Biomarker of the Absence of Hypercalciuria in Postsurgical Hypoparathyroidism.
García-Pascual L; Barahona MJ; Perea V; Simó R
J Clin Endocrinol Metab; 2017 Jan; 102(1):259-266. PubMed ID: 27813709
[TBL] [Abstract][Full Text] [Related]
37. The effects of patient and disease-related factors on the quality of life in patients with hypoparathyroidism.
Hepsen S; Akhanli P; Sakiz D; Sencar ME; Ucan B; Unsal IO; Cakal E; Ozbek M
Arch Osteoporos; 2020 May; 15(1):75. PubMed ID: 32430780
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Teriparatide in Patients with Hypoparathyroidism: A Prospective, Open-label Study.
Upreti V; Somani S; Kotwal N
Indian J Endocrinol Metab; 2017; 21(3):415-418. PubMed ID: 28553597
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control Study.
Underbjerg L; Sikjaer T; Rejnmark L
J Bone Miner Res; 2018 May; 33(5):822-831. PubMed ID: 29281760
[TBL] [Abstract][Full Text] [Related]
40. PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Palermo A; Santonati A; Tabacco G; Bosco D; Spada A; Pedone C; Raggiunti B; Doris T; Maggi D; Grimaldi F; Manfrini S; Vescini F
J Clin Endocrinol Metab; 2018 Jan; 103(1):271-280. PubMed ID: 29099939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
